The tally, one vote per house
21 of 25 research houses agree, +1 house in 30 days. See which houses, free →
Reshoring and supply-chain resilience spending is presented as a structural shift in which companies and governments trade efficiency for security, funding duplicate supply chains, onshoring and new industrial capacity. Researchers point to tariffs, subsidies and recent manufacturing and capex strength as support for US industrial activity. A minority of the 25 houses covering the theme, four, argue against it, mainly on the grounds that redundant supply chains add inflationary costs.
Each house counts once: its newest view on the theme in the last 60 days. The counts are computed, not written by AI; the summary is AI-written from the houses’ views, without names.
Who the houses are
- Asset managers9
- Banks8
- Independent research firms5
- Podcasts3
Types only: names are shown to members. See who said what, free →
Houses discussing it, 12 weeks
Houses with a view in the 60 days to each week’s end. Latest: 25 houses on 3 Nov.
What the theme implies
- US industrials higher
Positioning
Source: CFTC Commitments of Traders; FinChiefs calculations. Report of 27 Oct 2026. Positioning data →
Named in research
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Questions
What is the “Reshoring spend” theme?
Companies and governments prioritising resilience over efficiency spend on duplicate supply chains, onshoring and industrial capacity, lifting US industrial activity. It is one of 70 themes FinChiefs counts across published research from banks, asset managers, independent research firms and podcasts.
How many research houses agree?
21 of 25 research houses agree (84%), counting each house's newest view in the last 60 days: 21 agree, 0 are mixed and 4 disagree. That is +1 house in 30 days. Members see each house by name.
Which instruments do research houses name for this theme?
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.